QSAM Biosciences, Inc. logo

QSAM Biosciences, Inc.

OTC:QSAM

Overview | Financials
Company Name QSAM Biosciences, Inc.
Symbol QSAM
Currency USD
Price 7
Market Cap 23,015,580
Dividend Yield 0%
52-week-range 3.51 - 7.5
Industry Biotechnology
Sector Healthcare
CEO Mr. Douglas R. Baum
Website https://qsambio.com

An error occurred while fetching data.

About QSAM Biosciences, Inc.

QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage bone targeting radiopharmaceutical. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc.

Related Stocks

Medicure Inc. logo

Medicure Inc.

MCUJF

1.23 USD

Financials

Numbers are in millions USD

Numbers are in millions USD